When Cindy Mrotek and Katie Glenn each became caregivers for their parents with cholangiocarcinoma, they had no idea the ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is ...

The U.S. Food and Drug Administration (FDA) has approved Komzifti (ziftomenib), which is a type of treatment known as a menin ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

Scalp cooling helped Maureen Green prevent hair loss during chemotherapy, despite its initial financial burden due to lack of ...

The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.

I told my pastor through tears how much losing more of my hearing has impacted me. I already was hard of hearing from birth, ...

Tracy Milgram-Posner established BRCAStrong in 2015 after more than a decade of navigating her BRCA2 genetic mutation alone.